V-BOSE-GM2 – Tablets
An Abiding Antidiabetic combination for coherent Diabetic Control
COMPOSITION – Glimepiride IP 2 mg+ Voglibose 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
» A medium-to-long acting sulfonylurea anti-diabetic drug that exhibits a high potency.
» Improves insulin resistance in hyperinsulinemic patients.
» Categorized under the class of Alpha-glucosidase inhibitor used in the management of type 2 diabetes.
» Used for lowering post-prandial blood glucose levels in people with diabetes mellitus.
- Triple drug combination is safe and effective in patients with type 2 diabetes.
Glimepiride IP 2 mg+ Voglibose 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)